Table 1.
Demographic, clinical, laboratory, metabolic and instrumental features of 224 hepatocellular carcinoma patients n (%)
| Variable | HCC patients (n = 224)1 |
| Mean age (yr) | 54.6 ± 10.7 |
| Male sex | 190 (84.8) |
| Liver cirrhosis | 122 (54.5) |
| Diabetes mellitus | 27 (12.1) |
| Overweight or obesitya | 95 (58.6) |
| Hypertension | 59 (26.3) |
| Body weight (kg) | 68.8 ± 11.0 |
| Body heighta (cm) | 169.4 ± 6.4 |
| Mean body mass indexa (kg/m2) | 23.9 ± 3.4 |
| Systolic blood pressure (mmHg) | 128 ± 16 |
| Diastolic blood pressure (mmHg) | 79 ± 9 |
| Mean artery pressure (mmHg) | 95 ± 10 |
| Past history of HBV infection | 173 (77.2) |
| Smoking | 99 (44.2) |
| Alcohol intake | 69 (30.8) |
| Positive for HBeAgb | 52 (26.1) |
| HBV-DNAc, Log10 | 5.32 ± 1.40 |
| AFPd, > 400 ng/mL | 110 (50.9) |
| Child-Pugh Score2 | 6 (5-8) |
| Blood Glucose (mmol/L) | 5.88 ± 2.22 |
| Total Bilirubin2 (mg/L) | 13 (8-23) |
| Albumin level (g/L) | 36.6 ± 6.3 |
| International normalized ratio | 1.22 ± 0.24 |
| Alanine aminotransferase2 (U/L) | 53 (34-83) |
| γ-glutamyl transferase2 (U/L) | 113 (58-254) |
| Platelet count2 (× 109/L) | 125 (81-183) |
| Triglyceridese (mmol/L) | 1.02 ± 0.52 |
| Total cholesterole (mmol/L) | 4.27 ± 1.33 |
| HDL cholesterolf (mmol/L) | 0.93 ± 0.44 |
| LDL cholesterolf (mmol/L) | 2.44 ± 1.06 |
| Creatinine2 (mg/dL) | 0.9 (0.8-1.0) |
| Blood urea nitrogen2 (mmol/L) | 4.98 (3.92-6.28) |
1
Plus-minus value indicates mean ± SD;
2
Median (inter-quartile range, Q1-Q3). Data were available in
a
162,
b
199,
c
57,
d
216,
e
148 and
f
132 patients. AFP: α-fetoprotein; HBV: Hepatitis B virus; HDL: High-density lipoprotein; LDL: Low-density lipoprotein.